Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients

Do Intiso, M. M. Zarrelli, G. Lagioia, F. Di Rienzo, C. Checchia De Ambrosio, P. Simone, P. Tonali, R. P. Cioffi

Research output: Contribution to journalArticle

Abstract

Experimental evidence indicates that tumor necrosis factor alpha (TNF-α) is involved in brain damage following ischemic injury. The present study was designed to monitor serum TNF-α levels in acute stroke patients and to correlate TNF-α levels with lesion size, neurological impairment and vascular risk factors. In 41 patients with ischemic stroke, serum TNF-α levels were serially measured by a solid enzyme amplified sensitivity immunoassay (EASIA) in the first 10 days after stroke onset. Serum fibrinogen and C-reactive protein (CRP), white blood cell (WBC) and neutrophil counts were determined on the same days to monitor acute phase response changes. Lesion size was calculated on computed tomograms by a computer-assisted procedure. Neurological impairment was evaluated on the Canadian Neurological Scale. Forty age-matched subjects were used as controls. Compared to baseline, TNF-α levels significantly increased during the study (p=0.0001), peaking on day 7. Peak TNF-α levels did not correlate with neurological impairment or lesion size. Multivariate analysis showed that sex, age, vascular risk factors and infectious complications did not influence TNF-α levels. Fibrinogen, CRP, WBC and neutrophil concentrations increased, indicating an acute phase response occurred after stroke. In conclusion, serum TNF-α levels showed an early and prolonged increase after stroke onset, unrelated to lesion size, neurological impairment, age, sex, vascular risk factors or infectious complications. Serum increase of TNF-α may be explained as part of the acute phase response occurring in stroke patients.

Original languageEnglish
Pages (from-to)390-396
Number of pages7
JournalNeurological Sciences
Volume24
Issue number6
DOIs
Publication statusPublished - Feb 2004

Fingerprint

Tumor Necrosis Factor-alpha
Stroke
Serum
Acute-Phase Reaction
C-Reactive Protein
Fibrinogen
Neutrophils
Leukocyte Count
Immunoassay
Leukocytes
Multivariate Analysis
Wounds and Injuries
Brain
Enzymes
vascular factor

Keywords

  • Computed tomography
  • Cytokine
  • Inflammation response
  • Ischemic stroke
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. / Intiso, Do; Zarrelli, M. M.; Lagioia, G.; Di Rienzo, F.; Checchia De Ambrosio, C.; Simone, P.; Tonali, P.; Cioffi, R. P.

In: Neurological Sciences, Vol. 24, No. 6, 02.2004, p. 390-396.

Research output: Contribution to journalArticle

Intiso, D, Zarrelli, MM, Lagioia, G, Di Rienzo, F, Checchia De Ambrosio, C, Simone, P, Tonali, P & Cioffi, RP 2004, 'Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients', Neurological Sciences, vol. 24, no. 6, pp. 390-396. https://doi.org/10.1007/s10072-003-0194-z
Intiso, Do ; Zarrelli, M. M. ; Lagioia, G. ; Di Rienzo, F. ; Checchia De Ambrosio, C. ; Simone, P. ; Tonali, P. ; Cioffi, R. P. / Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. In: Neurological Sciences. 2004 ; Vol. 24, No. 6. pp. 390-396.
@article{638b925cc6974ed18b9170347af8bb27,
title = "Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients",
abstract = "Experimental evidence indicates that tumor necrosis factor alpha (TNF-α) is involved in brain damage following ischemic injury. The present study was designed to monitor serum TNF-α levels in acute stroke patients and to correlate TNF-α levels with lesion size, neurological impairment and vascular risk factors. In 41 patients with ischemic stroke, serum TNF-α levels were serially measured by a solid enzyme amplified sensitivity immunoassay (EASIA) in the first 10 days after stroke onset. Serum fibrinogen and C-reactive protein (CRP), white blood cell (WBC) and neutrophil counts were determined on the same days to monitor acute phase response changes. Lesion size was calculated on computed tomograms by a computer-assisted procedure. Neurological impairment was evaluated on the Canadian Neurological Scale. Forty age-matched subjects were used as controls. Compared to baseline, TNF-α levels significantly increased during the study (p=0.0001), peaking on day 7. Peak TNF-α levels did not correlate with neurological impairment or lesion size. Multivariate analysis showed that sex, age, vascular risk factors and infectious complications did not influence TNF-α levels. Fibrinogen, CRP, WBC and neutrophil concentrations increased, indicating an acute phase response occurred after stroke. In conclusion, serum TNF-α levels showed an early and prolonged increase after stroke onset, unrelated to lesion size, neurological impairment, age, sex, vascular risk factors or infectious complications. Serum increase of TNF-α may be explained as part of the acute phase response occurring in stroke patients.",
keywords = "Computed tomography, Cytokine, Inflammation response, Ischemic stroke, Tumor necrosis factor",
author = "Do Intiso and Zarrelli, {M. M.} and G. Lagioia and {Di Rienzo}, F. and {Checchia De Ambrosio}, C. and P. Simone and P. Tonali and Cioffi, {R. P.}",
year = "2004",
month = "2",
doi = "10.1007/s10072-003-0194-z",
language = "English",
volume = "24",
pages = "390--396",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "6",

}

TY - JOUR

T1 - Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients

AU - Intiso, Do

AU - Zarrelli, M. M.

AU - Lagioia, G.

AU - Di Rienzo, F.

AU - Checchia De Ambrosio, C.

AU - Simone, P.

AU - Tonali, P.

AU - Cioffi, R. P.

PY - 2004/2

Y1 - 2004/2

N2 - Experimental evidence indicates that tumor necrosis factor alpha (TNF-α) is involved in brain damage following ischemic injury. The present study was designed to monitor serum TNF-α levels in acute stroke patients and to correlate TNF-α levels with lesion size, neurological impairment and vascular risk factors. In 41 patients with ischemic stroke, serum TNF-α levels were serially measured by a solid enzyme amplified sensitivity immunoassay (EASIA) in the first 10 days after stroke onset. Serum fibrinogen and C-reactive protein (CRP), white blood cell (WBC) and neutrophil counts were determined on the same days to monitor acute phase response changes. Lesion size was calculated on computed tomograms by a computer-assisted procedure. Neurological impairment was evaluated on the Canadian Neurological Scale. Forty age-matched subjects were used as controls. Compared to baseline, TNF-α levels significantly increased during the study (p=0.0001), peaking on day 7. Peak TNF-α levels did not correlate with neurological impairment or lesion size. Multivariate analysis showed that sex, age, vascular risk factors and infectious complications did not influence TNF-α levels. Fibrinogen, CRP, WBC and neutrophil concentrations increased, indicating an acute phase response occurred after stroke. In conclusion, serum TNF-α levels showed an early and prolonged increase after stroke onset, unrelated to lesion size, neurological impairment, age, sex, vascular risk factors or infectious complications. Serum increase of TNF-α may be explained as part of the acute phase response occurring in stroke patients.

AB - Experimental evidence indicates that tumor necrosis factor alpha (TNF-α) is involved in brain damage following ischemic injury. The present study was designed to monitor serum TNF-α levels in acute stroke patients and to correlate TNF-α levels with lesion size, neurological impairment and vascular risk factors. In 41 patients with ischemic stroke, serum TNF-α levels were serially measured by a solid enzyme amplified sensitivity immunoassay (EASIA) in the first 10 days after stroke onset. Serum fibrinogen and C-reactive protein (CRP), white blood cell (WBC) and neutrophil counts were determined on the same days to monitor acute phase response changes. Lesion size was calculated on computed tomograms by a computer-assisted procedure. Neurological impairment was evaluated on the Canadian Neurological Scale. Forty age-matched subjects were used as controls. Compared to baseline, TNF-α levels significantly increased during the study (p=0.0001), peaking on day 7. Peak TNF-α levels did not correlate with neurological impairment or lesion size. Multivariate analysis showed that sex, age, vascular risk factors and infectious complications did not influence TNF-α levels. Fibrinogen, CRP, WBC and neutrophil concentrations increased, indicating an acute phase response occurred after stroke. In conclusion, serum TNF-α levels showed an early and prolonged increase after stroke onset, unrelated to lesion size, neurological impairment, age, sex, vascular risk factors or infectious complications. Serum increase of TNF-α may be explained as part of the acute phase response occurring in stroke patients.

KW - Computed tomography

KW - Cytokine

KW - Inflammation response

KW - Ischemic stroke

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=1342291175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342291175&partnerID=8YFLogxK

U2 - 10.1007/s10072-003-0194-z

DO - 10.1007/s10072-003-0194-z

M3 - Article

C2 - 14767684

AN - SCOPUS:1342291175

VL - 24

SP - 390

EP - 396

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 6

ER -